News

SAN FRANCISCO, CA / ACCESS Newswire / July 2, 2025 / The Bay Area CBT Center has unveiled a groundbreaking offering: fully ...
VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, ...
The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...
The Patient Engagement Solutions Market is expected to witness a CAGR of 13-17 % in the forecast period, due to the ...
The Contrast Media Market is projected to grow at a CAGR of 5-6%. Key factors influencing the contrast media market include ...
Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ...
The Neurodiagnostics Market is projected to experience a growth rate of 7-8 % between 2023 and 2028. This growth is fueled by ...
Brussels, 30 JuneStefan Oelrich, President of Bayer’s Pharmaceuticals Division has been elected as the new President of the ...
Smile Digital Health is the first vendor to be validated by NCQA as qualified to run digital HEDIS measures with their dQM ...
Aurobindo Pharma’s Dazublys, a trastuzumab biosimilar for HER2-positive cancers, gains EU approval, enhancing access to ...
Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic ...
Stefan Oelrich, President of the European Federation of Pharmaceutical Industries and Associations (EFPIA), has called for ...